Partnership Proposal · Joint Venture
LB Lab. Middle East
A proposed joint venture between Nuriva Trading L.L.C and LB Lab to bring the professional skincare portfolio to the Gulf and Egypt — equal partners, starting in the UAE.
A proposed joint venture between Nuriva Trading L.L.C and LB Lab to bring the professional skincare portfolio to the Gulf and Egypt — equal partners, starting in the UAE.
The joint-venture model sizes both the prize and the launch cost. Revenue is shared equally as it grows; the first six months of expenditure are funded equally to get there.
| Product Category | Price (AED) | Mix | Y1 Rev | Y2 Rev | Y3 Rev | Y4 Rev | Y5 Rev | 5-Yr Rev | 5-Yr Units |
|---|---|---|---|---|---|---|---|---|---|
| Hydrodermabrasion SerumsLB Fusion · 3 SKUs | 900 | 25% | 151,200 | 277,509 | 466,215 | 624,395 | 923,106 | 2,442,426 | 2,714 |
| Microneedling Ampoules6 SKUs · 5×10 ml | 850 | 35% | 214,200 | 388,513 | 652,703 | 874,155 | 1,292,351 | 3,421,922 | 4,026 |
| Chemical Peelings7 SKUs incl. AZELA, GLYC, SAL… | 580 | 25% | 149,640 | 277,509 | 466,215 | 624,395 | 923,106 | 2,440,866 | 4,208 |
| Peel-Off Masques8 SKUs · 180 gr | 210 | 15% | 90,720 | 166,506 | 279,730 | 374,638 | 553,865 | 1,465,459 | 6,978 |
| Total — all categories | — | 100% | 605,760 | 1,110,038 | 1,864,863 | 2,497,584 | 3,692,429 | 9,770,674 | 17,926 |
| Operating Expenses | Y1 · 2026 | Y2 · 2027 | Y3 · 2028 | Y4 · 2029 | Y5 · 2030 | 5-Year |
|---|---|---|---|---|---|---|
| Sales Team · 6 → 9 reps | 810,000 | 810,000 | 1,060,000 | 1,060,000 | 1,060,000 | 4,800,000 |
| Marketing & Sampling | 50,000 | 100,000 | 200,000 | 250,000 | 350,000 | 950,000 |
| G&A / Logistics | 40,000 | 40,000 | 50,000 | 50,000 | 60,000 | 240,000 |
| Total OpEx | 900,000 | 950,000 | 1,310,000 | 1,360,000 | 1,470,000 | 5,990,000 |
Both partners fund the venture's first six months of expenditure equally — roughly AED 450K of launch outlay (six months of operating cost), split 50/50. Year 1 runs at a planned operating loss; the co-funding carries the launch period while revenue ramps.
Paid monthly. After the six-month launch window, the venture is funded from its own revenue.
Source: LB joint-venture model (5-year, 2026–2030). These figures align with the standalone UAE business plan, which is built from the same model. Figures are management projections in AED, not guarantees of future performance.
Because LB Lab supplies the goods free as part of the partnership, the venture carries only its operating costs. Year 1 is a co-funded investment; the venture turns operationally profitable in Year 2, and margins expand toward ~60% by Year 5. Every dirham of profit is shared 50/50.
| Profit & Loss (AED) | Y1 · 2026 | Y2 · 2027 | Y3 · 2028 | Y4 · 2029 | Y5 · 2030 | 5-Year |
|---|---|---|---|---|---|---|
| Net Revenue | 605,760 | 1,110,038 | 1,864,863 | 2,497,584 | 3,692,429 | 9,770,674 |
| Cost of GoodsSupplied free by LB Lab — in-kind | — | — | — | — | — | — |
| Operating Expenses | (900,000) | (950,000) | (1,310,000) | (1,360,000) | (1,470,000) | (5,990,000) |
| Operating Profit (EBIT) | (294,240) | 160,038 | 554,863 | 1,137,584 | 2,222,429 | 3,780,674 |
| EBIT margin | −48.6% | 14.4% | 29.8% | 45.5% | 60.2% | 38.7% |
Operating profit is split equally, just like revenue. Year 1 is a shared, co-funded investment; from Year 2 the venture is profitable and each partner's share grows quickly as revenue scales on a largely fixed cost base.
Both partners co-fund the first six months of operating cost; thereafter the venture is funded from its own revenue.
Under the partnership, LB Lab supplies the goods at no cost to the venture as its in-kind contribution, so the venture carries only operating expenses. Operating profit (EBIT) = net revenue − operating expenses, shared 50/50 between the partners. Revenue and operating-expense figures are taken from the joint-venture model; all are management projections in AED, not guarantees of future performance.
The work divides cleanly. LB Lab supplies the portfolio, the materials and its share of the funding; Nuriva Trading L.L.C runs everything on the ground in the UAE.
The partnership would be established as a UAE Free Zone Establishment — suggested name LB Lab. Middle East — giving both sides one clean vehicle to contract, invoice and grow from, market by market.
A Free Zone entity gives the venture a recognised regional base with straightforward foreign ownership, a clear contracting and invoicing structure, and a foundation that extends naturally from the UAE into Saudi Arabia, Egypt and the wider Gulf as each market opens.
Both partners hold the venture equally — a true 50/50 joint venture.
Two simple principles govern the UAE phase — an equal split of both the early investment and the income it generates.
Net revenue is split equally between Nuriva Trading L.L.C and LB Lab. This applies to the UAE for now; the economics for Saudi Arabia, Egypt and the remaining markets follow the same logic and are agreed market by market, referencing the forecasts in the main business plan.
Each partner funds half of the venture's expenditure for the first six months, paid on a monthly basis — sharing the cost of the launch period until the business begins to carry itself.
Neither side is a vendor to the other. LB Lab and Nuriva Trading L.L.C put in complementary contributions — product and operations — and take out an equal share of what the venture earns. The structure keeps incentives aligned: both partners win only when the venture sells.
Figures and forecasts referenced here live in the main business plan ›
The UAE is the proving ground, with terms defined here. The remaining markets open in sequence, each on terms agreed as it comes into scope.
Launch market. Revenue split and responsibilities defined in this proposal.
Next priority market, on terms agreed when it opens.
Follows Saudi Arabia, referencing the main-plan forecasts.
Wider Gulf countries phased in thereafter.
A new Free Zone Establishment would unite LB Lab's products and know-how with Nuriva Trading L.L.C's in-market operations — sharing the launch cost, the revenue, and the upside equally as the venture scales across the region.
For the UAE, the split and responsibilities are defined. Economics for the remaining markets follow the same partnership logic and are agreed as each market comes into scope, referencing the expected revenues in the main business plan.